Vivani Medical
VANI
57 hedge funds and large institutions have $10.2M invested in Vivani Medical in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 8 reducing their positions, and 10 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 8
179% more call options, than puts
Call options by funds: $692K | Put options by funds: $248K
0% more funds holding
Funds holding: 57 → 57 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
19% less capital invested
Capital invested by funds: $12.6M → $10.2M (-$2.36M)
Top Buyers
Top Sellers
VANI Hedge Fund Activity: Q2 2016 in Review
57 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2016, worth a combined $10.2M — down 19% from $12.6M a quarter earlier.
Fund positioning in VANI was balanced in Q2 2016: 10 funds opened new positions, 10 closed out, 32 added to existing stakes and 8 trimmed.
The largest buyer was Van Den Berg Management I, adding an estimated $666K. The largest seller was Harvest Capital Strategies, exiting entirely with an estimated $1.85M sold.
- 57 institutional investors held Vivani Medical (VANI) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $10.2M of Vivani Medical stock for Q2 2016, down 19% quarter-over-quarter.
- 10 funds opened new Vivani Medical positions in Q2 2016 and 10 closed out, a net change of 0 holders.
- The largest Vivani Medical buyer in Q2 2016 was Van Den Berg Management I, an estimated $666K added.
- The largest Vivani Medical seller in Q2 2016 was Harvest Capital Strategies, an estimated $1.85M sold.
Based on aggregated 13F filings for Q2 2016.